- Home
- ENSG
as of 12-03-2025 1:30pm EST
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SAN JUAN CAPISTRANO |
| Market Cap: | 10.5B | IPO Year: | 2007 |
| Target Price: | $196.40 | AVG Volume (30 days): | 450.6K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.59 | EPS Growth: | 35.03 |
| 52 Week Low/High: | $118.73 - $194.00 | Next Earning Date: | 11-03-2025 |
| Revenue: | $4,829,467,000 | Revenue Growth: | 17.55% |
| Revenue Growth (this year): | 19.99% | Revenue Growth (next year): | 10.84% |
AI-Powered ENSG Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of The Ensign Group Inc. (ENSG)
President and COO
Avg Cost/Share
$180.00
Shares
3,690
Total Value
$664,200.00
Owned After
51,165
SEC Form 4
President and COO
Avg Cost/Share
$180.00
Shares
2,209
Total Value
$397,620.00
Owned After
51,165
SEC Form 4
Director
Avg Cost/Share
$178.57
Shares
1,000
Total Value
$178,570.00
Owned After
24,126
SEC Form 4
President and COO
Avg Cost/Share
$177.30
Shares
5,899
Total Value
$1,045,892.70
Owned After
51,165
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$181.13
Shares
28,315
Total Value
$5,116,699.74
Owned After
60,981
Director
Avg Cost/Share
$182.08
Shares
73
Total Value
$13,291.84
Owned After
14,490
SEC Form 4
Director
Avg Cost/Share
$188.87
Shares
246
Total Value
$46,462.02
Owned After
8,879.149
SEC Form 4
Director
Avg Cost/Share
$180.64
Shares
700
Total Value
$126,448.00
Owned After
25,052
SEC Form 4
Director
Avg Cost/Share
$172.00
Shares
700
Total Value
$120,400.00
Owned After
25,052
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Burton Spencer | ENSG | President and COO | Nov 20, 2025 | Sell | $180.00 | 3,690 | $664,200.00 | 51,165 | |
| Burton Spencer | ENSG | President and COO | Nov 18, 2025 | Sell | $180.00 | 2,209 | $397,620.00 | 51,165 | |
| Shaw Daren | ENSG | Director | Nov 18, 2025 | Sell | $178.57 | 1,000 | $178,570.00 | 24,126 | |
| Burton Spencer | ENSG | President and COO | Nov 17, 2025 | Sell | $177.30 | 5,899 | $1,045,892.70 | 51,165 | |
| Port Barry | ENSG | Chief Executive Officer | Nov 12, 2025 | Sell | $181.13 | 28,315 | $5,116,699.74 | 60,981 | |
| Uychiat Pison Marivic | ENSG | Director | Nov 7, 2025 | Sell | $182.08 | 73 | $13,291.84 | 14,490 | |
| Agwunobi John O | ENSG | Director | Nov 6, 2025 | Sell | $188.87 | 246 | $46,462.02 | 8,879.149 | |
| SMITH BARRY M | ENSG | Director | Nov 3, 2025 | Sell | $180.64 | 700 | $126,448.00 | 25,052 | |
| SMITH BARRY M | ENSG | Director | Oct 1, 2025 | Sell | $172.00 | 700 | $120,400.00 | 25,052 |
Compare ENSG vs Leading Stocks
See how ENSG stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ENSG The Ensign Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.